Webinar: Democratizing Clinical Research
Scaling Access & Inclusion for Clinical Trial Participation
Register for our FREE educational webinar on
Wednesday, March 3rd at 1PM EDT (10AM PDT)
Webinar recording coming soon. Please register below for access.
Scaling access & inclusion to clinical research is key to finding medications, therapies & treatments that work for all.
In a friendly and live conversational format, this free webinar will discuss:
- Current state: Demographics of clinical trial enrollment
- What are the barriers to clinical trial participation?
- Ways to engage with diverse and under-represented communities
- The role of technology in building an inclusive clinical research paradigm
- Critical focus areas for increasing access and diversity
- And other conversational topics
You will hear from clinical research professionals in a moderated conversation.
Scott Schliebner, SVP, Scientific Affairs & Therapeutic Expertise Head, Center for Rare Diseases, PRA Health Sciences, Moderator
Mr. Schliebner is a clinical development executive with a 25-year background focused on rare diseases, innovation, and patient-focused approaches to drug development. He is passionate about reducing the burden of clinical trial participation and leveraging novel approaches and technologies to bring new therapies to patients faster. Mr. Schliebner also serves as the Co-Chair of Global Genes’ Corporate Alliance, serves on the Board of Directors for Uplifting Athletes, and supports several rare disease panels and committees. He holds a Master’s Degree in Public Health (MPH) from the University of Utah School of Medicine, and completed a Graduate Research Fellowship at The National Institutes of Health.
Veer Mehta, Founder & CEO, Halo Health Systems, Panelist
Mr. Mehta is the founder and CEO at Halo Health Systems, a digital platform that accelerates clinical trials for pharma. With over 15 years of medical industry experience, he has extensive experience in the development & launch of FDA approved medical devices and digital health solutions. Veer has led engineering teams that have worked closely with large medical device and pharma companies, developing innovative technologies in the areas of endocrinology, cardiology, and immunology therapeutics. His passion for improving patient centricity in healthcare has led to an accomplished career in medical technologies, improving the lives of patients, clinicians, and researchers.
Teneasha Washington, PhD, MPH, Assistant Professor, University of Alabama at Birmingham School of Public Health, Department of Health Behavior, Panelist
Dr. Washington is the Founder of The Washington Group, a consulting agency, that focuses on addressing client’s needs in a variety of specialty areas. In addition, her current research
focuses on serving as the lead of community engagement efforts for the Mindfulness, Exercise, Nutrition, to Optimize Resilience (MENTOR) program. In this role, she develops micro-funding
announcement opportunities for local communities to implement programs relevant to their needs. In addition, she develops and provides in-person and online trainings focused on
community engagement, program implementation, and building sustainable partnerships among communities, non-profits, and academia. She currently serves as the lead of diversity
initiatives at RARE-X. In addition, she is a QM-certified professor teaching undergraduate and graduate students in the UAB School of Public Health on community organizing, social and
behavioral sciences, intervention development, and research methods. Washington holds degrees from UAB (BS, Biology; MPH, Public Health; PhD, Health Education/Health Promotion,
Public Health; Present MBA, expected graduation summer 2022).
Jennifer Fields, MPH, President, The Hills Tandem, Panelist
Ms. Fields is the Founder and President of The Hills Tandem and has over 17 years of experience working with non-profit organizations as a change agent to improve organizational impact. Additionally, she works with pharmaceutical companies to improve national level patient engagement through building team knowledge, awareness and advocacy infrastructure. Her current work includes partnerships with the Pacific Sickle Cell Regional Collaborative, the Sickle Cell Disease Foundation (California) where she was a lead in developing a $15 million proposal to improve access to care for adults living with sickle cell disease; and several Pharma companies. Jennifer wears multiple hats as a strategist, public health expert and person who lives with a chronic rare blood disorder.